SUN PHARMACEUTICAL INDUSTRIES
Back to Cashflow Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-1,437 Cr | ₹860 Cr | ₹4,735 Cr | ₹-608 Cr | ₹-1,934 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-1,437 Cr |
| Mar2025 | ₹860 Cr |
| Mar2024 | ₹4,735 Cr |
| Mar2023 | ₹-608 Cr |
| Mar2022 | ₹-1,934 Cr |
How is Net Cash Inflow / Outflow of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-1,437 Cr | Negative | |
| Mar2025 | ₹860 Cr | -81.83 | |
| Mar2024 | ₹4,735 Cr | Positive | |
| Mar2023 | ₹-608 Cr | Negative | |
| Mar2022 | ₹-1,934 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹425,144.0 Cr | 0.8% | -2.1% | 4.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,265.0 Cr | 4.9% | 7.9% | 54.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | 1.6% | -2.7% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,351.0 Cr | 2.6% | 14.2% | 3.9% | Stock Analytics | |
| CIPLA | ₹112,474.0 Cr | 2.4% | 3.4% | -12% | Stock Analytics | |
| MANKIND PHARMA | ₹102,315.0 Cr | -0.3% | -2% | 2.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 0.8% |
-2.1% |
4.8% |
| SENSEX | 4.5% |
6.1% |
-9.3% |
You may also like the below Video Courses